Jackson ImmunoResearch

Antibody Description	Unconjugated	NEW DyLight 405 A=400, E=421	Coumarin AMCA A=350, E=450	Cyanine Cy2 A=492, E=510	DyLight 488 A=493, E=518	Fluorescein FITC A=492, E=520	DyLight 549 A=555, E=568	Cyanine Cy3 A=550, E=570	Rhodamine TRITC A=550, E=570	Rhodamine Red-X RRX A=570, E=590	Texas Red TR A=596, E=620	DyLight 594 A=591, E=616	DyLight 649 A=652, E=670	Cyanine Cy5 A=650, E=670	Biotin-SP (long spacer)	Horseradish Peroxidase	Alkaline Phosphatase
Goat Anti-Horse IgG (H+L)	€ 89 / 2.0 mg 108-005-003	€ 144 / 2.0 mg 108-475-003	€ 126 / 2.0 mg 108-155-003	€ 137 / 2.0 mg 108-225-003	€ 144 / 2.0 mg 108-485-003	€ 110 / 2.0 mg 108-095-003	€ 144 / 2.0 mg 108-505-003	€ 137 / 2.0 mg 108-165-003	€ 110 / 2.0 mg 108-025-003	€ 110 / 2.0 mg 108-295-003	€ 130 / 2.0 mg 108-075-003	€ 144 / 2.0 mg 108-515-003	€ 144 / 2.0 mg 108-495-003	€ 137 / 2.0 mg 108-175-003	€ 135 / 2.0 ml 108-065-003	€ 135 / 2.0 ml 108-035-003	€ 171 / 1.0 ml 108-055-003
Goat Anti-Horse IgG, Fc fragment specific	107 / 2.0 108-005-008	193 / 2.0 108-475-008	167 / 2.0 108-155-008	183 / 2.0 108-225-008	193 / 2.0 108-485-008	145 / 2.0 108-095-008	193 / 2.0 108-505-008	183 / 2.0 108-165-008	145 / 2.0 108-025-008	145 / 2.0 108-295-008	173 / 2.0 108-075-008	193 / 2.0 108-515-008	193 / 2.0 108-495-008	183 / 2.0 108-175-008	177 / 2.0 108-065-008	177 / 2.0 108-035-008	203 / 1.0 108-055-008
Rabbit Anti-Horse IgG (H+L)	123 / 2.0 308-005-003	144 / 1.5 308-475-003	126 / 1.5 308-155-003	137 / 1.5 308-225-003	144 / 1.5 308-485-003	116 / 1.5 308-095-003	144 / 1.5 308-505-003	137 / 1.5 308-165-003	116 / 1.5 308-025-003	116 / 1.5 308-295-003	130 / 1.5 308-075-003	144 / 1.5 308-515-003	144 / 1.5 308-495-003	137 / 1.5 308-175-003	163 / 1.5 308-065-003	163 / 1.5 308-035-003	176 / 1.0 308-055-003
Rabbit Anti-Horse IgG, Fc fragment specific															203 / 1.5 308-065-008	203 / 1.5 308-035-008


♦		Warning: BSA and dry milk may contain IgG which will react with this antibody. Use of BSA and/or dry milk to block or dilute this antibody may increase background and/or reduce secondary antibody titer.